Clinical trial
Study on the Effects of Mesenchymal Stem Cell Culture Supernatant on the Prevention and Treatment of Mucosal Injury in Hematology Patients
NCT06599346 is registered in ClinicalTrials.gov with The General Hospital of Western Theater Command as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Effects of Mesenchymal Stem Cell Culture Supernatant on the Prevention and Treatment of Mucosal Injury in Hematology Patients
- Lead sponsor
- The General Hospital of Western Theater Command
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 1, 2020
- Completion date
- September 30, 2025
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced mucositis, hematopoietic stem cell transplantation, mucositis, radiation-induced mucositis